UCSF Medical Center

NBME Recognizes Dr. Karen Hauer with Prestigious Medical Education Research Award

Retrieved on: 
Tuesday, April 2, 2024
Medical education, Internal medicine, Education, UCSF, Communication, Learning, Science, International, Patient, Bias, Knowledge, Research, University, Doctor of Philosophy, Faculty, MD, Student, Thought, MBA, UCSF Medical Center, Habit, Stanford University, Feedback, Physician, Health, NBME, Nursing

PHILADELPHIA, April 02, 2024 (GLOBE NEWSWIRE) -- Karen Hauer, MD, PhD, was selected as the recipient of NBME’s 2024 John P. Hubbard Award in recognition of her significant contributions to the field of medical education research and assessment.

Key Points: 
  • PHILADELPHIA, April 02, 2024 (GLOBE NEWSWIRE) -- Karen Hauer, MD, PhD, was selected as the recipient of NBME’s 2024 John P. Hubbard Award in recognition of her significant contributions to the field of medical education research and assessment.
  • NBME President and CEO Peter Katsufrakis, MD, MBA, echoes her sentiments about past Hubbard Award recipients and expresses his support and admiration for Dr. Hauer and her accomplishments.
  • She is an active researcher in health professions education with a focus on competency-based medical education, workplace-based assessment, equity and coaching.
  • P. Hubbard Award recognizes individuals for their outstanding contributions to the pursuit of assessment excellence within medical education.

Paragonix Technologies Announces Nationwide Commercial Availability of FDA-Cleared BAROguard™ Donor Lung Preservation System

Retrieved on: 
Thursday, April 4, 2024
FDA, Health Technology, Health, Medical Devices, Lung, Massachusetts General Hospital, International Society, Transplant, Patient, Duke University Hospital, Research, Standard of care, Lung transplantation, MD, Surgeon, MSC, UCSF Medical Center, Atmosphere, Hospital, UCLA, Heart, UCLA Health, Medical device

Paragonix Technologies, Inc. , a pioneer in organ transplant technologies and procurement services, announces the full commercial launch of its next-generation transport device, the BAROguard™ Donor Lung Preservation System .

Key Points: 
  • Paragonix Technologies, Inc. , a pioneer in organ transplant technologies and procurement services, announces the full commercial launch of its next-generation transport device, the BAROguard™ Donor Lung Preservation System .
  • First-of-its-kind, the novel BAROguard system combines clinically proven hypothermic preservation techniques alongside active airway management control to ensure that donor lungs maintain optimal conditions during transport for maximum protection.
  • Paragonix Technologies received FDA 510(k) clearance for the device in August 2023, and conducted its first-in-human case at Duke University Medical Center in November 2023.
  • “The commercial launch of BAROguard represents a significant breakthrough for the organ transplantation industry,” said Dr. Lisa Anderson, CEO and President of Paragonix Technologies.

Transformative Gift from Salesforce Chair and CEO Marc Benioff and Lynne Benioff Will Expand Access and Continuity of Healthcare in Hawai'i

Retrieved on: 
Tuesday, March 5, 2024
UCSF, SAN, HELP, Hospital, Philosophy, Education, Partnership, Health, Burn, Community hospital, Straub Medical Center, Patient, Family, Queen, MBBS, UCSF Medical Center, Neurology

SAN FRANCISCO, March 5, 2024 /PRNewswire/ -- A major donation by longstanding philanthropists in Hawai'i will significantly increase healthcare access, addressing critical infrastructure gaps and helping ensure excellent and continuous care for communities in Hawai'i.

Key Points: 
  • The $150 million gift by Marc and Lynne Benioff is one of the largest single private donations in Hawai'i's history.
  • It provides $100 million for Hawai'i Pacific Health, one of the state's largest nonprofit healthcare organizations, to help create a "healthcare campus of the future" at Honolulu-based Straub Medical Center.
  • "Hilo Medical Center's mission is to provide the best possible healthcare for our family, friends and neighbors," says Dan Brinkman, CEO of Hilo Medical Center.
  • "We are truly grateful for this extremely generous and transformational gift," said Ray Vara, president and CEO of Hawai'i Pacific Health.

UpDoc Debuts the World's First AI Assistant That Manages Medication Prescriptions and Chronic Conditions

Retrieved on: 
Friday, January 5, 2024
Cloud, Patient, Azure, Google Cloud, Stanford University, Doctor of Pharmacy, Microsoft, RPI, UCSF Medical Center, Health care, American Heart Association, Physician, Research, Health literacy, Microsoft Band, Conditional sentence, Diabetes, Health, MD, Prescription, Medicine, Health equity, Polaris Partners, Standard of care, Eli Lilly and Company, Remote patient monitoring, RPM, Perception, Mayo Clinic, JAMA Network Open, Stanford University Medical Center, Organization, Corporation, Medical device

UpDoc aims to deliver a clinician-directed AI provider to every patient's home through accessible technology that improves access to high quality, affordable care.

Key Points: 
  • UpDoc aims to deliver a clinician-directed AI provider to every patient's home through accessible technology that improves access to high quality, affordable care.
  • All care delivered through the AI is prescribed by physicians or clinical pharmacists who oversee the platform.
  • By scaling provider reach, the AI assistant is also designed to improve efficiency and reduce clinical burnout.
  • We are eager to see what opportunities AI can offer in helping patients make sense of their medications and better manage their health."

ulrich medical USA® Announces FDA Clearance for Expanded Indications of Momentum® and Momentum® MIS Systems

Retrieved on: 
Wednesday, December 20, 2023
UCSF Medical Center, FDA, Surgeon, Deformity, MD, G21, Assistant, Patient, Pelvis, Pharmaceutical industry

PLANO, Texas, Dec. 20, 2023 /PRNewswire/ -- ulrich medical USA, the pioneer in expandable corpectomy devices and a market leader in spine technology, today announced FDA clearance for expanded indications of the Momentum and Momentum MIS Posterior Spinal Fixation Systems. The expanded indications allow for both Momentum and Momentum MIS systems to be used in conjunction with G21 V-STEADY Radiopaque Bone Cement to help restore the integrity of the spinal column in patients with advanced stage tumors.

Key Points: 
  • PLANO, Texas, Dec. 20, 2023 /PRNewswire/ -- ulrich medical USA, the pioneer in expandable corpectomy devices and a market leader in spine technology, today announced FDA clearance for expanded indications of the Momentum and Momentum MIS Posterior Spinal Fixation Systems.
  • The expanded indications allow for both Momentum and Momentum MIS systems to be used in conjunction with G21 V-STEADY Radiopaque Bone Cement to help restore the integrity of the spinal column in patients with advanced stage tumors.
  • The Momentum and Momentum MIS Posterior Spinal Fixation Systems are used to provide stabilization, fixation and correction of the thoracolumbar and sacroiliac spine.
  • "We are pleased to have received this expanded indication from the FDA", said Eric Lucas, Ph.D., Vice President of Technology at ulrich medical USA.

By the Bay Health, Mission Hospice & Home Care, and Hope Hospice Merge to Become the Largest Independent Not-for-Profit Hospice Network in Northern California

Retrieved on: 
Thursday, November 30, 2023
MSN, SAN, UCSF Medical Center, Organization, Life, Nursing, Transitional care, RN, History, California Department, Patient, Person-centered therapy, Health, Mission House, Social, Palliative care, Physician, California Department of Finance, Education, Residential care, San Francisco Bay Area, Peninsula

LARKSPUR, Calif. and SAN MATEO, Calif. and DUBLIN, Calif., Nov. 30, 2023 /PRNewswire/ -- By the Bay Health, Mission Hospice & Home Care, and Hope Hospice today announced they will merge to become the largest independent not-for-profit hospice network in Northern California, uniquely positioned to provide compassionate care and impactful community services to more patients and families throughout the region.

Key Points: 
  • The three organizations are among the longest-standing not-for-profit hospices in California: By the Bay Health was the state's first hospice, while Mission was the first not-for-profit hospice in San Mateo County and Hope one of the earliest not-for-profit hospices serving the East Bay Tri-Valley.
  • This affiliation remains in place expanding a comprehensive Bay Area network that addresses the multifaceted health needs of patients and families.
  • "Mission Hospice, By the Bay Health, and Hope Hospice share a rich history and commitment to serving the Bay Area community with comprehensive end-of-life care, education, and grief support," said Mission Hospice CEO Dolores Miller, RN, MN.
  • As a stronger combined organization, we can continue to provide compassionate end-of-life care that prioritizes the needs of patients and their families."

Canopy Health Announces New CEO

Retrieved on: 
Monday, November 13, 2023
UCSF Medical Center, UnitedHealth Group, HMO, Blue Shield, John Muir Health, Retirement, Growth, Hospital, Physician, Wood, Knowledge, HealthNet, Health, Management, San Francisco Bay Area

EMERYVILLE, Calif., Nov. 13, 2023 /PRNewswire/ -- Canopy Health, a Bay Area joint venture originally founded by John Muir Health and UCSF Health, announced the planned retirement of Mike Robinson as CEO effective at the end of the year. Ken Wood, a seasoned Bay Area health care executive, will serve as Canopy Health's CEO effective immediately.

Key Points: 
  • EMERYVILLE, Calif., Nov. 13, 2023 /PRNewswire/ -- Canopy Health, a Bay Area joint venture originally founded by John Muir Health and UCSF Health, announced the planned retirement of Mike Robinson as CEO effective at the end of the year.
  • Ken Wood, a seasoned Bay Area health care executive, will serve as Canopy Health's CEO effective immediately.
  • "The Canopy Health board of directors would like to thank Mike Robinson for his five years of service, which saw the organization grow to provide HMO coverage to more than 50,000 Bay Area residents," said Mike Thomas, chair of the Canopy Health board and the president and CEO of John Muir Health.
  • "The Canopy Health board is pleased that Ken Wood was available to step in and ably lead the organization through a planned growth phase," said Shelby Decosta, vice chair of the Canopy Health board and president of the UCSF Health Affiliates Network.

ATEC to Preview the Informatics Sophistication of EOS Catalyst™ at NASS 2023

Retrieved on: 
Tuesday, October 17, 2023
Technology, Surgery, Public Relations, Investor Relations, Communications, Health Technology, Software, General Health, Health, Data Management, Artificial Intelligence, EOS, Spine, Orthopedic surgery, Data collection, Informatics, Deformity, Catalysis, UCSF Medical Center, Adolescence, Elective surgery, ATEC, Scoliosis, MD

Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that EOS Catalyst will be introduced at the 2023 NASS Annual Meeting.

Key Points: 
  • Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that EOS Catalyst will be introduced at the 2023 NASS Annual Meeting.
  • EOS Catalyst builds on the already unprecedented functionality of the EOS imaging platform with automated alignment and surgical planning capabilities.
  • “EOS is foundational to ATEC’s mission to revolutionize spine surgery,” said Pat Miles, Chairman and Chief Executive Officer.
  • I can’t wait to incorporate the groundbreaking workflow efficiencies and clinical predictability that EOS Catalyst will make possible.

Cerus Corporation Announces Workshop and Abstracts at the 2023 AABB Annual Meeting

Retrieved on: 
Tuesday, October 10, 2023
General Health, Health, Other Health, CDT, American Red Cross, Central Time Zone, Abstract, University of Texas Southwestern Medical Center, UCSF Medical Center, Transfusion medicine, University, Stanford University, Corporation, CERS, Use, Pharmaceutical industry, Vaccine, Cerus Corporation

Cerus Corporation (Nasdaq:CERS) today announced a selection of abstracts and an industry workshop at the 2023 AABB Annual Meeting, taking place in Nashville, TN from October 14 through October 17.

Key Points: 
  • Cerus Corporation (Nasdaq:CERS) today announced a selection of abstracts and an industry workshop at the 2023 AABB Annual Meeting, taking place in Nashville, TN from October 14 through October 17.
  • This year’s AABB Annual Meeting attracts individuals and institutions from around the globe involved in the fields of transfusion medicine and biotherapies.
  • The following is a select list of presentations and abstracts of interest for Cerus.
  • Sunday, October 15, 2023 – 10:00 a.m.– Pathogen Reduced Cryoprecipitate: Early Experiences and Inventory Management Outcomes (Chair: M.S.

FDA Grants Second Breakthrough Device Designation for Carlsmed Technology

Retrieved on: 
Wednesday, September 20, 2023
Health, FDA, Medical Devices, Surgery, Physical Therapy, Other Health, Biotechnology, 3D, UCSF Medical Center, Surgeon, Patient, Risk, Birth control

Carlsmed announced today that the FDA granted Breakthrough Device designation for its aprevo® technology for treatment of patients with cervical spine disease.

Key Points: 
  • Carlsmed announced today that the FDA granted Breakthrough Device designation for its aprevo® technology for treatment of patients with cervical spine disease.
  • This is Carlsmed’s second Breakthrough Device designation, complementing the company’s family of lumbar patient-specific interbody fusion devices for anterior, lateral, and transforaminal approaches.
  • “Our goal is to accelerate deployment of patient-centric pioneering technology that revolutionizes the standard of care for spine surgery,” said Mike Cordonnier , CEO of Carlsmed.
  • Carlsmed’s aprevo® device for the treatment of cervical spine disease is anticipated to be launched in the U.S. in 2025.